antianginal/trötthet

Länken sparas på Urklipp

Välj sorteringstyp

14 resultat

Effect of propranolol and verapamil on oxygen utilization, acidosis and fatigue during exercise in stable angina pectoris.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Oxygen utilization, arterial and venous blood gas levels, hemodynamic values and exercise tolerance were compared before and after administration of propranolol and verapamil in 10 patients with stable angina pectoris. During exercise, propranolol decreased cardiac output (CO) by 22%; O2 extraction

The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effect.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Ten men with stable angina not completely relieved by full doses of propranolol (mean 218 mg/day) were administered an oral dose of 10 mg of nifedipine or placebo on alternate mornings in a double-blind fashion. Patients had been trained in a protocol that precipitated angina after 3-6 minutes of

Heart rate slowing versus other pharmacological antianginal strategies.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Relieving the symptoms of angina and improving the quality of life and functional status are important objectives in the management of patients with chronic stable angina. A high heart rate induces or exacerbates myocardial ischemia and angina because it both increases oxygen demand and decreases

ATP-sensitive potassium channels.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

ATP-sensitive potassium (K(ATP)) channels link membrane excitability to metabolism. They are regulated by intracellular nucleotides and by other factors including membrane phospholipids, protein kinases and phosphatases. K(ATP) channels comprise octamers of four Kir6 pore-forming subunits associated

[TTS-nitroglycerin and slow-release metoprolol: efficacy in patients with stable exercise-induced angina].

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The antianginal efficacy of slow-release metoprolol (SRM) alone and associated to a transdermal therapeutic system containing nitroglycerin (TTS-TNG), was investigated in 10 patients with chronic, stable exertional angina and angiographic evidence of obstructive coronary artery disease, by means of

Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Conventional formulations of metoprolol have become well established in cardiovascular medicine and are particularly useful in the management of hypertension and ischaemic heart disease. Recently developed controlled release metoprolol delivery systems (metoprolol CR/ZOK and metoprolol OROS) were

Unsuspected giant cell arteritis diagnosed at open heart surgery.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

A 62-year-old patient undergoing aortocoronary bypass grafting had giant cell arteritis diagnosed by routine aortic biopsy done at the graft insertion site. This finding led to the tissue diagnosis of temporal arteritis and the institution of steroid therapy. In retrospect, vague symptoms of

[A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris].

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

In 242 patients with hypertension and/or angina pectoris, a new cardioselective betablocker without ISA, bisoprolol (Concor), was tested. The average mean value of 168/102 mm Hg was lowered in the 174 hypertensive patients by a systolic value of 17 and a diastolic value of 11 mm Hg. A normal

Verapamil in angina pectoris.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

New knowledge of the pathophysiology of coronary disease has helped determine the therapy for angina pectoris. Calcium antagonists have the advantage of being direct coronary vasodilators as well as decreasing overall demand by systemic vasodilatation. Verapamil has the same anti-anginal effect

Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Amlodipine, a potent long-acting dihydropyridine calcium antagonist, was compared with placebo in a parallel, randomized, double-blind study in 134 patients with chronic stable angina pectoris maintained on beta-adrenergic blocking agents. After a single-blind, two-week placebo period, patients were

Alternative medical treatment for patients with angina pectoris and adverse reactions to beta blockers. Usefulness of nifedipine.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Although beta blockers are effective for the treatment of angina pectoris, chronic adverse effects produced by these agents--including lethargy, fatigue, and male impotence--can adversely affect patient acceptance and treatment compliance. To assess the clinical effects of switching from

The effect of timolol vs placebo on angina pectoris.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The effect of timolol vs placebo on the frequency of anginal episodes, nitroglycerin consumption and exercise performance was investigated in a double-blind, randomized, crossover study in 23 patients with angina pectoris. The optimal dose of timolol (10-30 mg twice daily) for each patient was

Therapeutic targets in ischaemic heart disease.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The adequate treatment of a disease syndrome is dependent upon a clear definition of the symptomatic, pathological, physiological and prognostic targets against which therapy is to be deployed. The syndromes of ischaemic heart disease, including angina pectoris, are complex in origin, pathology,

Evaluation of the beta-blocking drug acebutolol in angina pectoris.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The effects of the beta-adernergic blocking drug acebutolol were studied in 23 patients with angina pectoris and angiographically documented coronary artery disease. Patients were evaluated clinically, by graded treadmill testing and by 24-hour Holter monitoring in the control state, after 2 weeks

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning